Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October-2020 Volume 20 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2020 Volume 20 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Involvement of angiotensin II receptor type 1/NF‑κB signaling in the development of endometriosis

  • Authors:
    • Zhimin Zhang
    • Yi Yuan
    • Lian He
    • Xiaoguang Yao
    • Jingwei Chen
  • View Affiliations / Copyright

    Affiliations: Department of Obstetrics, The Fourth Hospital of Shijiazhuang City, Shijiazhuang, Hebei 050011, P.R. China, Department of Obstetrics and Gynecology, Zhejiang Hospital, Hangzhou, Zhejiang 310030, P.R. China, Hebei Key Laboratory of Integrative Medicine on Liver‑Kidney Patterns, Institute of Integrative Medicine, College of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3269-3277
    |
    Published online on: July 29, 2020
       https://doi.org/10.3892/etm.2020.9071
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Endometriosis (EM) is a common disease in women; however, the signaling pathways and related genes underlying the mechanisms of EM remain unclear. The present study aimed to investigate the role of angiotensin II receptor type 1 (AGTR1) in the pathogenesis of EM. Human EM tissues were collected, and the expression levels of AGTR1 and NF‑κB in the tissues were analyzed using immunochemistry and western blotting, while the estrogen levels in the EM tissues were determined by ELISA. In vitro human endometrial stromal cells were used to investigate the expression levels of AGTR1 following exposure to estrogen; the interaction between AGTR1 and NF‑κB was determined using reverse transcription‑quantitative PCR and western blotting; and the effects of AGTR1 on cell proliferation, as well as the apoptotic and migratory abilities of the cells were evaluated using WST‑1 assays, wound healing assays and flow cytometry, respectively. It was observed that both the expression levels of AGTR1 and the activity of NF‑κB were increased in human EM tissues and stromal cells, and this activation of AGTR1 subsequently increased the activity of NF‑κB. Moreover, estrogen was found to regulate the expression levels of AGTR1 in stromal cells. The activation of AGTR1 was demonstrated to promote cell proliferation and migration, in addition to preventing cells from undergoing apoptosis. In conclusion, the present study suggested that the increased activity of the AGTR1‑NF‑κB axis following the decreased exposure to estrogen may be important for the pathogenesis of EM. In addition, AGTR1 may be a potential therapeutic target for the treatment of EM.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Czyzyk A, Podfigurna A, Szeliga A and Meczekalski B: Update on endometriosis pathogenesis. Minerva Ginecol. 69:447–461. 2017.PubMed/NCBI View Article : Google Scholar

2 

Cramer DW and Missmer SA: The epidemiology of endometriosis. Ann N Y Acad Sci. 955:11–22, Discussion 34-16, 396-406. 2002.PubMed/NCBI View Article : Google Scholar

3 

Garcia-Velasco JA and Somigliana E: Management of endometriomas in women requiring IVF: To touch or not to touch. Hum Reprod. 24:496–501. 2009.PubMed/NCBI View Article : Google Scholar

4 

Diao R, Wei W, Zhao J, Tian F, Cai X and Duan YG: CCL19/CCR7 contributes to the pathogenesis of endometriosis via PI3K/Akt pathway by regulating the proliferation and invasion of ESCs. Am J Reprod Immunol. 7(e12744)2017.PubMed/NCBI View Article : Google Scholar

5 

Pazhohan A, Amidi F, Akbari-Asbagh F, Seyedrezazadeh E, Farzadi L, Khodarahmin M, Mehdinejadiani S and Sobhani A: The Wnt/β-catenin signaling in endometriosis, the expression of total and active forms of β-catenin, total and inactive forms of glycogen synthase kinase-3β, WNT7a and DICKKOPF-1. Eur J Obstet Gynecol Reprod Biol. 220:1–5. 2017.PubMed/NCBI View Article : Google Scholar

6 

Zhang Z, Ruan L, Lu M and Yao X: Analysis of key candidate genes and pathways of endometriosis pathophysiology by a genomics-bioinformatics approach. Gynecol Endocrinol. 35:576–581. 2019.PubMed/NCBI View Article : Google Scholar

7 

Park YA, Choi CH, Do IG, Song SY, Lee JK, Cho YJ, Choi JJ, Jeon HK, Ryu JY, Lee YY, et al: Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma. Gynecol Oncol. 135:108–117. 2014.PubMed/NCBI View Article : Google Scholar

8 

Watanabe Y, Shibata K, Kikkawa F, Kajiyama H, Ino K, Hattori A, Tsujimoto M and Mizutani S: Adipocyte-derived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angiotensin system. Clin Cancer Res. 9:6497–6503. 2003.PubMed/NCBI

9 

Hsieh YY, Chang CC, Chen SY, Chen CP, Lin WH and Tsai FJ: XRCC1 399 Arg-related genotype and allele, but not XRCC1 His107Arg, XRCC1 Trp194Arg, KCNQ2, AT1R, and hOGG1 polymorphisms, are associated with higher susceptibility of endometriosis. Gynecol Endocrinol. 28:305–309. 2012.PubMed/NCBI View Article : Google Scholar

10 

MacKenzie A: Endothelium-derived vasoactive agents, AT1 receptors and inflammation. Pharmacol Ther. 131:187–203. 2011.PubMed/NCBI View Article : Google Scholar

11 

Wei X and Shao X: Nobiletin alleviates endometriosis via down-regulating NF-κB activity in endometriosis mouse model. Biosci Rep. 38(BSR20180470)2018.PubMed/NCBI View Article : Google Scholar

12 

Taniguchi F, Uegaki T, Nakamura K, Mon KY, Harada T and Ohbayashi T: Inhibition of IAP (inhibitor of apoptosis) proteins represses inflammatory status via nuclear factor-kappa B pathway in murine endometriosis lesions. Am J Reprod Immunol. 79:2018.PubMed/NCBI View Article : Google Scholar

13 

Diop-Frimpong B, Chauhan VP, Krane S, Boucher Y and Jain RK: Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci USA. 108:2909–2914. 2011.PubMed/NCBI View Article : Google Scholar

14 

Block M, Fister S, Emons G, Seeber S, Gründker C and Günthert AR: Antiproliferative effects of antiestrogens and inhibitors of growth factor receptor signaling on endometrial cancer cells. Anticancer Res. 30:2025–2031. 2010.PubMed/NCBI

15 

Slopien R and Meczekalski B: Aromatase inhibitors in the treatment of endometriosis. Prz Menopauzalny. 15:43–47. 2016.PubMed/NCBI View Article : Google Scholar

16 

Polin SA and Ascher SM: The effect of tamoxifen on the genital tract. Cancer Imaging. 8:135–145. 2008.PubMed/NCBI View Article : Google Scholar

17 

Podolin PL, Callahan JF, Bolognese BJ, Li YH, Carlson K, Davis TG, Mellor GW, Evans C and Roshak AK: Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell Proliferation. J Pharmacol Exp Ther. 312:373–381. 2005.PubMed/NCBI View Article : Google Scholar

18 

Chatterjee S, Malhotra R, Varghese F, Bukhari AB, Patil A, Budrukkar A, Parmar V, Gupta S and De A: Quantitative immunohistochemical analysis reveals association between sodium iodide symporter and estrogen receptor expression in breast cancer. PLoS One. 8(e54055)2013.PubMed/NCBI View Article : Google Scholar

19 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

20 

Reis FM, Petraglia F and Taylor RN: Endometriosis: Hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum Reprod Update. 19:406–418. 2013.PubMed/NCBI View Article : Google Scholar

21 

Nehme A, Zouein FA, Zayeri ZD and Zibara K: An update on the tissue renin angiotensin system and its role in physiology and pathology. J Cardiovasc Dev Dis. 6(14)2019.PubMed/NCBI View Article : Google Scholar

22 

Herr D, Bekes I and Wulff C: Local renin-angiotensin system in the reproductive system. Front Endocrinol (Lausanne). 4(150)2013.PubMed/NCBI View Article : Google Scholar

23 

Vinson GP, Teja R, Ho MM, Hinson JP and Puddefoot JR: The role of the tissue renin-angiotensin system in the response of the rat adrenal to exogenous angiotensin II. J Endocrinol. 158:153–159. 1998.PubMed/NCBI View Article : Google Scholar

24 

Yoshimura Y: The ovarian renin-angiotensin system in reproductive physiology. Front Neuroendocrinol. 18:247–291. 1997.PubMed/NCBI View Article : Google Scholar

25 

Brunswig-Spickenheier B and Mukhopadhyay AK: Local regulatory factors in regulation of ovarian function: Role of prorenin-renin-angiotensin-system. Indian J Exp Biol. 41:669–681. 2003.PubMed/NCBI

26 

Abraham F, Sacerdoti F, De Leon R, Gentile T and Canellada A: Angiotensin II activates the calcineurin/NFAT signaling pathway and induces cyclooxygenase-2 expression in rat endometrial stromal cells. PLoS One. 7(e37750)2012.PubMed/NCBI View Article : Google Scholar

27 

Kowalczyńska LJ, Ferenc T, Wojciechowski M, Mordalska A, Pogoda K and Malinowski A: Endometriosis and RAS system gene polymorphisms: The association of ACE A2350G polymorphism with endometriosis in Polish individuals. DNA Cell Biol. 33:328–335. 2014.PubMed/NCBI View Article : Google Scholar

28 

Nakao T, Chishima F, Sugitani M, Tsujimura R, Hayashi C and Yamamoto T: Expression of angiotensin II types 1 and 2 receptors in endometriotic lesions. Gynecol Obstet Invest. 82:294–302. 2017.PubMed/NCBI View Article : Google Scholar

29 

King AE, Critchley HO and Kelly RW: The NF-kappaB pathway in human endometrium and first trimester decidua. Mol Hum Reprod. 7:175–183. 2001.PubMed/NCBI View Article : Google Scholar

30 

Kaponis A, Iwabe T, Taniguchi F, Ito M, Deura I, Decavalas G, Terakawa N and Harada T: The role of NF-kappaB in endometriosis. Front Biosci (Schol Ed). 4:1213–1234. 2012.PubMed/NCBI View Article : Google Scholar

31 

Luca M, Huang S, Gershenwald JE, Singh RK, Reich R and Bar-Eli M: Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol. 151:1105–1113. 1997.PubMed/NCBI

32 

Nie J, Lu Y, Liu X and Guo SW: Immunoreactivity of progesterone receptor isoform B, nuclear factor kappaB, and IkappaBalpha in adenomyosis. Fertil Steril. 92:886–889. 2009.PubMed/NCBI View Article : Google Scholar

33 

Park H, Kim SH, Cho YM, Ihm HJ, Oh YS, Hong SH, Chae HD, Kim CH and Kang BM: Increased expression of nuclear factor kappa-B p65 subunit in adenomyosis. Obstet Gynecol Sci. 59:123–129. 2016.PubMed/NCBI View Article : Google Scholar

34 

Li X, Zhang YJ, Meng Y, Zhou GS and Zhang ZS: Effect of angiotensin II type 1 receptor and angiotensin-converting enzyme gene silencing on nuclear factor-kappaB activity in hepatic stellate cells. Nan Fang Yi Ke Da Xue Xue Bao. 29:402–404. 2009.(In Chinese). PubMed/NCBI

35 

Du N, Feng J, Hu LJ, Sun X, Sun HB, Zhao Y, Yang YP and Ren H: Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling. Oncol Rep. 27:1893–1903. 2012.PubMed/NCBI View Article : Google Scholar

36 

Ekambaram P, Lee JL, Hubel NE, Hu D, Yerneni S, Campbell PG, Pollock N, Klei LR, Concel VJ, Delekta PC, et al: The CARMA3-Bcl10-MALT1 signalosome drives NFκB activation and promotes aggressiveness in angiotensin II receptor-positive breast cancer. Cancer Res. 78:1225–1240. 2018.PubMed/NCBI View Article : Google Scholar

37 

Jia G, Stormont RM, Gangahar DM and Agrawal DK: Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification. Am J Physiol Heart Circ Physiol. 303:H523–H532. 2012.PubMed/NCBI View Article : Google Scholar

38 

Galvankar M, Singh N and Modi D: Estrogen is essential but not sufficient to induce endometriosis. J Biosci. 42:251–263. 2017.PubMed/NCBI View Article : Google Scholar

39 

Wang X, Mamillapalli R, Mutlu L, Du H and Taylor HS: Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cells is mediated by estradiol regulated CXCL12 and CXCR4 expression. Stem Cell Res. 15:14–22. 2015.PubMed/NCBI View Article : Google Scholar

40 

Dotan I, Werner L, Vigodman S, Weiss S, Brazowski E, Maharshak N, Chen O, Tulchinsky H, Halpern Z and Guzner-Gur H: CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system. Inflamm Bowel Dis. 16:583–592. 2010.PubMed/NCBI View Article : Google Scholar

41 

Cunha-Filho JS, Gross JL, Bastos de Souza CA, Lemos NA, Giugliani C, Freitas F and Passos EP: Physiopathological aspects of corpus luteum defect in infertile patients with mild/minimal endometriosis. J Assist Reprod Genet. 20:117–121. 2003.PubMed/NCBI View Article : Google Scholar

42 

Smith MP, Keay SD, Margo FC, Harlow CR, Wood PJ, Cahill DJ and Hull MG: Total cortisol levels are reduced in the periovulatory follicle of infertile women with minimal-mild endometriosis. Am J Reprod Immunol. 47:52–56. 2002.PubMed/NCBI View Article : Google Scholar

43 

Kooptiwut S, Wanchai K, Semprasert N, Srisawat C and Yenchitsomanus PT: Estrogen attenuates AGTR1 expression to reduce pancreatic β-cell death from high glucose. Sci Rep. 7(16639)2017.PubMed/NCBI View Article : Google Scholar

44 

Gao H, Yallampalli U and Yallampalli C: Protein restriction to pregnant rats increases the plasma levels of angiotensin II and expression of angiotensin II receptors in uterine arteries. Biol Reprod. 86(68)2012.PubMed/NCBI View Article : Google Scholar

45 

Nickenig G, Baumer AT, Grohe C, Bäumer AT, Grohè C, Kahlert S, Strehlow K, Rosenkranz S, Stäblein A, Beckers F, et al: Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation. 97:2197–2201. 1998.PubMed/NCBI View Article : Google Scholar

46 

Xue Q, Xiao D and Zhang L: Estrogen regulates angiotensin II receptor expression patterns and protects the heart from ischemic injury in female rats. Biol Reprod. 93(6)2015.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang Z, Yuan Y, He L, Yao X and Chen J: Involvement of angiotensin II receptor type 1/NF‑κB signaling in the development of endometriosis. Exp Ther Med 20: 3269-3277, 2020.
APA
Zhang, Z., Yuan, Y., He, L., Yao, X., & Chen, J. (2020). Involvement of angiotensin II receptor type 1/NF‑κB signaling in the development of endometriosis. Experimental and Therapeutic Medicine, 20, 3269-3277. https://doi.org/10.3892/etm.2020.9071
MLA
Zhang, Z., Yuan, Y., He, L., Yao, X., Chen, J."Involvement of angiotensin II receptor type 1/NF‑κB signaling in the development of endometriosis". Experimental and Therapeutic Medicine 20.4 (2020): 3269-3277.
Chicago
Zhang, Z., Yuan, Y., He, L., Yao, X., Chen, J."Involvement of angiotensin II receptor type 1/NF‑κB signaling in the development of endometriosis". Experimental and Therapeutic Medicine 20, no. 4 (2020): 3269-3277. https://doi.org/10.3892/etm.2020.9071
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Z, Yuan Y, He L, Yao X and Chen J: Involvement of angiotensin II receptor type 1/NF‑κB signaling in the development of endometriosis. Exp Ther Med 20: 3269-3277, 2020.
APA
Zhang, Z., Yuan, Y., He, L., Yao, X., & Chen, J. (2020). Involvement of angiotensin II receptor type 1/NF‑κB signaling in the development of endometriosis. Experimental and Therapeutic Medicine, 20, 3269-3277. https://doi.org/10.3892/etm.2020.9071
MLA
Zhang, Z., Yuan, Y., He, L., Yao, X., Chen, J."Involvement of angiotensin II receptor type 1/NF‑κB signaling in the development of endometriosis". Experimental and Therapeutic Medicine 20.4 (2020): 3269-3277.
Chicago
Zhang, Z., Yuan, Y., He, L., Yao, X., Chen, J."Involvement of angiotensin II receptor type 1/NF‑κB signaling in the development of endometriosis". Experimental and Therapeutic Medicine 20, no. 4 (2020): 3269-3277. https://doi.org/10.3892/etm.2020.9071
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team